跳至主要内容
临床试验/NCT00828412
NCT00828412已完成4 期

A Randomized, Investigator-Blind, Six-Week, Parallel Group, Multicenter Pilot Study to Compare the Safety and Efficacy of EpiCeram Skin Barrier Emulsion and Desonide Cream 0.05% in the Twice Daily Treatment of Pediatric Subjects With Moderate Atopic Dermatitis

Promius Pharma, LLC5 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
5
主要终点
Change From Baseline in Three Item Severity Score

研究概览

简要总结

This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
3 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • at least 3 months of age and less than 13 years of age
  • atopic dermatitis of moderate severity

排除标准

  • pregnant or lactating
  • treatment of atopic dermatitis with topical product in the 14 days prior to Baseline
  • treatment of atopic dermatitis with systemic product in the 30 days prior to Baseline
  • serious or uncontrolled medical condition
  • active infection
  • significant use of inhaled, intranasal, or intraocular corticosteroid

研究组 & 干预措施

1

Active Comparator

EpiCeram Skin Barrier Emulsion

干预措施: EpiCeram Skin Barrier Emulsion (Device)

2

Active Comparator

Desonide Cream 0.05%

干预措施: Desonide Cream 0.05% (Drug)

结局指标

主要结局

Change From Baseline in Three Item Severity Score

时间窗: Baseline to 6 weeks

The average of the sum of scores for erythema, edema/papulation, and excoriation for two target lesions. Scoring on a scale of 0 to 3 (none to severe). Maximum score is 9.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验